Adjuvant Leuprolide With or Without Docetaxel in Patients With High-Risk Prostate Cancer After Radical Prostatectomy (TAX-3501): Important Lessons for Future Trials

BACKGROUND: The current trial evaluated 2 common therapies for patients with advanced prostate cancer, docetaxel and hormonal therapy (HT), in the surgical adjuvant setting. METHODS: TAX-3501 was a randomized, phase 3, adjuvant study post-radical prostatectomy (RP) in high-risk patients with prostat...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Schweizer, Michael T., Huang, Peng, Kattan, Michael W., Kibel, Adam S., de Wit, Ronald, Sternberg, Cora N., Epstein, Jonathan I., Eisenberger, Mario A.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2013
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4124610/
https://ncbi.nlm.nih.gov/pubmed/23943299
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.28270
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk